… However, identity rises dramatically when the M. tuberculosis trHbO sequence is compared
with the orthologue sequences from Mycobacterium avium (84%),Mycobacterium leprae (83…

Background Experimental and clinical evidence supports the role of inflammation in
atherosclerosis and its complications. Colchicine is an orally administered, potent antiinflammatory …

Background Reduction of inflammation with colchicine has emerged as a therapeutic option
for secondary prevention of cardiovascular disease (CVD) in patients with coronary artery …

Aims Heart rate reduction is the cornerstone of the treatment of angina. The purpose of this
study was to explore the prognostic value of heart rate in patients with stable coronary artery …

Truncated hemoglobins (trHbs) are low-molecular-weight oxygen-binding heme-proteins
distributed in eubacteria, cyanobacteria, unicellular eukaryotes, and in higher plants, …

ContextFew randomized controlled trials have evaluated the efficacy of treatments for major
depression in patients with coronary artery disease (CAD). None have simultaneously …

ContextHigh-density lipoprotein (HDL) cholesterol is an inverse predictor of coronary
atherosclerotic disease. Preliminary data have suggested that HDL infusions can induce …

Background: Although numerous methods of postoperative analgesia have been investigated
in an attempt to improve pain control after total knee arthroplasty, parenteral narcotics still …

Aims The COLchicine Cardiovascular Outcomes Trial (COLCOT) demonstrated the benefits
of targeting inflammation after myocardial infarction (MI). We aimed to determine whether …

… for years in a competition between host immunity and M. tuberculosis growth, indicating that
an … Sequence analysis showed that M. tuberculosis trHbN and trHbO are identical to their M. …